Institutional Investor13h
Biopharma IPO Interest Peaks Following Strong Reception
A dozen hedge funds, including Perceptive, Farallon, and Marshall Wace, will benefit from companies that either went public ...
Institutional Investor16h
Tailoring Strategies for Nonprofits: Research, Resiliency, and OCIOs
With expertise in strategic asset allocation, quantitative modeling, macro and fundamental research, technical research, and ...
Institutional Investor12h
After IBM, There Was Buzz About the Return of Corporate Pensions. Now It’s Getting Serious.
More companies are considering resurrecting their frozen pensions or offering new ones to employees, says WTW’s Carl Hess.
Institutional Investor14h
Managers’ Bullish Outlooks Remain — But the Price of Gold Is Telling a Different Story
SSGA’s chief strategist is bullish on the metal as a natural hedge to geopolitical uncertainty and volatility — not just inflation.